跳至主要内容
临床试验/CTRI/2018/06/014588
CTRI/2018/06/014588尚未招募未知

Efficacy of acitretin in acquired dermal macular hyperpigmentation: An open label pilot study

ot applicable0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方
ot applicable

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Patients with a cliniopathological diagnosis of ADMH (acquired dermal macular hyperpigmentation)
  • 2. Age >18 years

排除标准

  • 1. Age < 18 years.
  • 2. Pregnancy/Lactation
  • 3. Child bearing age females with incomplete family status
  • 4. Patients refusing practice of contraceptive measures
  • 5. Patients with severe hepatic, renal disease or dyslipidemia
  • 6. Pre existing malignancy

研究者

发起方
ot applicable

相似试验